AbbVie (NYSE: ABBV) has completed its acquisition of Apogee Therapeutics (NASDAQ: APGE), paying $135.11 per share in cash for a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions